Is there a need for rescreening of patients treated for genital chlamydial infections?

Research output: Contribution to journalDebate/Note/Editorial


The present communication reviews reasons to perform rescreening of chlamydia-infected persons. It brings up difficulties to differentiate between relapse and reinfection. Studies on follow-up of chlamydia-positive cases after therapy are reviewed. It also highlights reasons for therapeutic failure, like compliance, pharmacological factors, including poor bioavailability, wrong dose regimens, lack of adherence to drug intake, neglect of partner notification and concomitant therapy in consorts, possible development of resistance to drugs generally prescribed, false negative or false positive diagnostic tests and reinfection from extra-genital not 'cured' sites. The review points to the need to establish programmes for routine rescreening of chlamydia-infected persons.


Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Infectious Medicine


  • genital infection, rescreening, chlamydia
Original languageEnglish
Pages (from-to)363-367
JournalInternational Journal of STD and AIDS
Issue number6
Publication statusPublished - 2002
Publication categoryResearch